142 related articles for article (PubMed ID: 9183225)
1. Should we measure lipoprotein Lp(a)?
Wilson PW; Kannel WB
Arch Intern Med; 1997 Jun; 157(11):1161-2. PubMed ID: 9183225
[No Abstract] [Full Text] [Related]
2. Lp(a) lipoprotein redux--from curious molecule to causal risk factor.
Kathiresan S
N Engl J Med; 2009 Dec; 361(26):2573-4. PubMed ID: 20032327
[No Abstract] [Full Text] [Related]
3. [An experience of lipoprotein (a) dosage in a Moroccan population of 184 subjects].
Fellat S; Lahfidi K; Sraïri JE; el Haïtem N; Mesbahi R; Ghanam R; Benomar M
Arch Mal Coeur Vaiss; 1997 Oct; 90(10):1371-6. PubMed ID: 9539837
[TBL] [Abstract][Full Text] [Related]
4. Lipoprotein Lp(a) excess and coronary heart disease.
Stein JH; Rosenson RS
Arch Intern Med; 1997 Jun; 157(11):1170-6. PubMed ID: 9183227
[TBL] [Abstract][Full Text] [Related]
5. Low LPA gene kringle IV-2 repeat copy number association with elevated lipoprotein (a) concentration as an independent risk factor of coronary atherosclerotic heart disease in the Chinese Han population.
Sun L; Zong M; Chen C; Xie L; Wu F; Yu M; Fan L
Lipids Health Dis; 2018 May; 17(1):111. PubMed ID: 29747697
[TBL] [Abstract][Full Text] [Related]
6. Lipoprotein(a) and coronary heart disease in Indian population.
Singh S; Dwivedi S; Melkani GC; Rani C; Gaur SP; Mandal SK; Mahua J
J Assoc Physicians India; 1999 Dec; 47(12):1157-60. PubMed ID: 11225215
[TBL] [Abstract][Full Text] [Related]
7. [Lipoprotein(a) as a biochemical marker of coronary atherosclerosis].
Ezhov MV; Afanas'ev OI; Benevolenskaia GF; Savchenko AP; Liakishev AA; Pokrovskiĭ SN
Ter Arkh; 1997; 69(9):31-4. PubMed ID: 9411822
[TBL] [Abstract][Full Text] [Related]
8. Apheresis in coronary heart disease with elevated Lp (a): a review of Lp (a) as a risk factor and its management.
Keller C
Ther Apher Dial; 2007 Feb; 11(1):2-8. PubMed ID: 17309568
[TBL] [Abstract][Full Text] [Related]
9. Plasma Lp(a) values in familial hypercholesterolemia and its relation to coronary heart disease.
Real JT; Ascaso JF; Chaves FJ; Tenés S; Priego MA; Puig O; Armengod ME; Carmena R
Nutr Metab Cardiovasc Dis; 1999 Feb; 9(1):41-4. PubMed ID: 10726108
[TBL] [Abstract][Full Text] [Related]
10. LDL-apheresis: indications and clinical experience in a tertiary cardiac centre.
Archontakis S; Pottle A; Hakim N; Ilsley C; Barbir M
Int J Clin Pract; 2007 Nov; 61(11):1834-42. PubMed ID: 17935547
[TBL] [Abstract][Full Text] [Related]
11. Estrogen-receptor polymorphism and hormone-replacement therapy.
Garrido JA
N Engl J Med; 2002 Sep; 347(10):762-3; author reply 762-3. PubMed ID: 12213951
[No Abstract] [Full Text] [Related]
12. Prevalence of low high-density lipoprotein cholesterol in patients with documented coronary heart disease or risk equivalent and controlled low-density lipoprotein cholesterol.
Alsheikh-Ali AA; Lin JL; Abourjaily P; Ahearn D; Kuvin JT; Karas RH
Am J Cardiol; 2007 Nov; 100(10):1499-501. PubMed ID: 17996508
[TBL] [Abstract][Full Text] [Related]
13. [Lipoprotein (a) and ischemic heart diseases in patients with type 2 diabetes].
Ben Hamda K; Masmoudi AS; Mandhouj O; Hammami S; Attia N; Smaoui M; Zidi MA; Nabli N; Chaaba R; Mahjoub S; Ben Farhat M; Hammami M
Arch Inst Pasteur Tunis; 2002; 79(1-4):27-33. PubMed ID: 15072242
[TBL] [Abstract][Full Text] [Related]
14. [Electrophoresis and the traditional method for the measurement of lipoprotein cholesterol in serum].
Wang JG; Xie XS
Hunan Yi Ke Da Xue Xue Bao; 2002 Feb; 27(1):51-4. PubMed ID: 12575236
[TBL] [Abstract][Full Text] [Related]
15. High-density vs low-density lipoprotein cholesterol as the risk factor for coronary artery disease and stroke in old age.
Weverling-Rijnsburger AW; Jonkers IJ; van Exel E; Gussekloo J; Westendorp RG
Arch Intern Med; 2003 Jul; 163(13):1549-54. PubMed ID: 12860577
[TBL] [Abstract][Full Text] [Related]
16. Lipoprotein (a) in patients with psoriasis: associations with lipid profiles and disease severity.
Pietrzak A; Kadzielewski J; Janowski K; Roliński J; Krasowska D; Chodorowska G; Paszkowski T; Kapeć E; Jastrzebska I; Tabarkiewicz J; Lotti T
Int J Dermatol; 2009 Apr; 48(4):379-87. PubMed ID: 19335423
[TBL] [Abstract][Full Text] [Related]
17. Lipoprotein(a) levels are increased in healthy young subjects with parental history of premature myocardial infarction.
Gaeta G; Cuomo S; Capozzi G; Foglia MC; Barra S; Madrid A; Stornaiuolo V; Trevisan M
Nutr Metab Cardiovasc Dis; 2008 Sep; 18(7):492-6. PubMed ID: 17962002
[TBL] [Abstract][Full Text] [Related]
18. Serum Lp(a) lipoprotein levels in patients with atherosclerotic occlusive disease of the lower extremities.
Dionyssiou-Asteriou A; Papastamatiou M; Vatalas I; Bastounis E
Eur J Vasc Endovasc Surg; 2000 Jul; 20(1):57-60. PubMed ID: 10906299
[TBL] [Abstract][Full Text] [Related]
19. Improving the prediction of cardiovascular risk: interaction between LDL and HDL cholesterol.
Grover SA; Dorais M; Coupal L
Epidemiology; 2003 May; 14(3):315-20. PubMed ID: 12859032
[TBL] [Abstract][Full Text] [Related]
20. Relation of clinical benefit of raising high-density lipoprotein cholesterol to serum levels of low-density lipoprotein cholesterol in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial).
Goldenberg I; Benderly M; Sidi R; Boyko V; Tenenbaum A; Tanne D; Behar S
Am J Cardiol; 2009 Jan; 103(1):41-5. PubMed ID: 19101227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
